pyrazinamide has been researched along with Infections, Mycobacterium in 25 studies
pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Substituted pyrazinoic acid esters have previously been reported to have in vitro activity against Mycobacterium avium and Mycobacterium kansasii as well as Mycobacterium tuberculosis." | 3.69 | Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters. ( Bergmann, KE; Cynamon, MH; Welch, JT, 1996) |
| "Pyrazinamide was only bacteriostatic in macrophages but weakly bactericidal during the first day of exposure in vitro." | 1.28 | Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254. ( Dhillon, J; Mitchison, DA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (40.00) | 18.7374 |
| 1990's | 5 (20.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 3 (12.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suga, S | 1 |
| Mukai, Y | 1 |
| Ishikawa, S | 1 |
| Yoshida, S | 1 |
| Paudel, S | 1 |
| Wada, T | 1 |
| Patsche, CB | 1 |
| Svensson, E | 1 |
| Wejse, C | 1 |
| Gravet, A | 1 |
| Souillard, N | 1 |
| Habermacher, J | 1 |
| Moser, A | 1 |
| Lohmann, C | 1 |
| Schmitt, F | 1 |
| Delarbre, JM | 1 |
| Ricart, JM | 1 |
| Martín, JM | 1 |
| Renau, A | 1 |
| Pérez, J | 1 |
| Cabria, F | 1 |
| Torres, MV | 1 |
| García-Cía, JI | 1 |
| Dominguez-Garrido, MN | 1 |
| Esteban, J | 1 |
| Jimenez, MS | 1 |
| Benito González, JJ | 1 |
| Benito González, F | 1 |
| Santa Cruz Ruiz, S | 1 |
| Gómez González, JL | 1 |
| Coscarón Blanco, E | 1 |
| Cordero Sánchez, M | 1 |
| del Cañizo Alvarez, A | 1 |
| SALIBA, A | 1 |
| BEATTY, OA | 1 |
| PFUETZE, KH | 1 |
| PYLE, MM | 1 |
| CORPE, RF | 1 |
| CHAVES, AD | 1 |
| Scholze, A | 1 |
| Loddenkemper, C | 1 |
| Grünbaum, M | 1 |
| Moosmayer, I | 1 |
| Offermann, G | 1 |
| Tepel, M | 1 |
| Göpel, B | 1 |
| Götte, K | 1 |
| Delaney, V | 1 |
| Sumrani, N | 1 |
| Hong, JH | 1 |
| Sommer, B | 1 |
| Bergmann, KE | 1 |
| Cynamon, MH | 1 |
| Welch, JT | 1 |
| Fisher, M | 1 |
| Tomlinson, DR | 1 |
| Coker, RJ | 1 |
| Schultsz, C | 1 |
| Kuijper, EJ | 1 |
| van Soolingen, D | 1 |
| Prins, JM | 1 |
| Arslan, H | 1 |
| Oner-Eyüboglu, F | 1 |
| Kalpaklioglu, F | 1 |
| Gürdogan, K | 1 |
| Akçay, S | 1 |
| Demirag, A | 1 |
| Haberal, M | 1 |
| Niemann, S | 1 |
| Richter, E | 1 |
| Rüsch-Gerdes, S | 1 |
| Bhalla, RK | 1 |
| Jones, TM | 1 |
| Rothburn, MM | 1 |
| Swift, AC | 1 |
| Heap, BJ | 1 |
| Dhillon, J | 1 |
| Mitchison, DA | 1 |
| Snider, DE | 1 |
| Farer, LS | 1 |
| Toida, I | 2 |
| Rauscher, CR | 1 |
| Kerby, G | 1 |
| Ruth, WE | 1 |
2 reviews available for pyrazinamide and Infections, Mycobacterium
| Article | Year |
|---|---|
Cervical lymphadenitis caused by Mycobacterium lentiflavum.
Topics: Abscess; Amoxicillin-Potassium Clavulanate Combination; Humans; Infant; Isoniazid; Lymph Nodes; Male | 2002 |
[Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Notificati | 2005 |
23 other studies available for pyrazinamide and Infections, Mycobacterium
| Article | Year |
|---|---|
INTENSIVE TREATMENT OF A CAPTIVE BORNEAN ELEPHANT (
Topics: Administration, Rectal; Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; E | 2021 |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; | 2014 |
[Culture and susceptibility testing of mycobacteria with VersaTREK].
Topics: Algorithms; Antitubercular Agents; Automation; Bacteriological Techniques; Culture Media; Ethambutol | 2011 |
Granulomatous lesion on the face successfully treated with antitubercular therapy.
Topics: Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Et | 2010 |
[Tuberculous otitis media. Report of 3 cases].
Topics: Adult; Aged; Amoxicillin; Antitubercular Agents; Cerebrospinal Fluid Otorrhea; Drug Combinations; Ea | 2003 |
DRUG RESISTANT MYCOBACTERIAL INFECTION AND ITS RESPONSE TO TREATMENT.
Topics: Cycloserine; Drug Resistance; Drug Resistance, Microbial; Humans; Isoniazid; Mycobacterium; Mycobact | 1963 |
RECENT ADVANCES IN TREATMENT OF ORGAN TUBERCULOSIS.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Antitubercular Agents; Child; Cycloserine; Ethionamide; I | 1964 |
CLINICAL ASPECTS, MEDICAL AND SURGICAL, IN THE MANAGEMENT OF BATTEY-TYPE PULMONARY DISEASE.
Topics: Bronchiectasis; Calcification, Physiologic; Drug Resistance; Drug Resistance, Microbial; Epidemiolog | 1964 |
PULMONARY TUBERCULOSIS.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Aminosalicylic Acids; Child; Cycloserine; Drug Resista | 1964 |
Cutaneous Mycobacterium abscessus infection after kidney transplantation.
Topics: Anti-Bacterial Agents; Clarithromycin; Humans; Kidney Transplantation; Male; Middle Aged; Mycobacter | 2005 |
Mycobacterial infections in renal allograft recipients.
Topics: Drug Therapy, Combination; Ethambutol; HIV Seropositivity; Humans; Immunosuppressive Agents; Isoniaz | 1993 |
Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Esters; Humans; Microbial Sensitivity | 1996 |
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group.
Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitu | 1996 |
Disseminated infection due to multidrug-resistant Mycobacterium bovis in a patient who was seropositive for human immunodeficiency virus.
Topics: Antibiotics, Antitubercular; Antitubercular Agents; DNA Fingerprinting; DNA, Bacterial; Drug Resista | 1996 |
Mycobacterial infections in solid organ transplant recipients.
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up S | 1999 |
Differentiation among members of the Mycobacterium tuberculosis complex by molecular and biochemical features: evidence for two pyrazinamide-susceptible subtypes of M. bovis.
Topics: Animals; Antitubercular Agents; Bacterial Typing Techniques; Cattle; Drug Resistance, Microbial; Hum | 2000 |
Tuberculous otitis media -- a diagnostic dilemma.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Drug Therapy, Combination; Ear Diseases; Faci | 2001 |
Mycobacterium simiae as a cause of intra-abdominal disease: a case report.
Topics: Abdomen; Adult; Ascitic Fluid; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Myco | 1989 |
Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254.
Topics: Animals; Antitubercular Agents; Culture Media; Hydrogen-Ion Concentration; In Vitro Techniques; Ison | 1989 |
Package inserts for antituberculosis drugs and tuberculins.
Topics: Antitubercular Agents; Child; Child, Preschool; Contraceptives, Oral; Drug Interactions; Drug Labeli | 1985 |
Pyrazinamide deamidase in tuberculous infection.
Topics: Amidohydrolases; Animals; Antigens; BCG Vaccine; Enzyme Repression; Female; Glycolipids; Liver; Male | 1973 |
Effect of pyrazinamide on nicotinamide adenine dinucleotide glycohydrolase of tuberculous host.
Topics: Animals; Drug Resistance, Microbial; Isoniazid; Liver; Male; Mice; Mycobacterium Infections; Mycobac | 1973 |
A ten-year clinical experience with Mycobacterium kansasii.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Child; Cycloserine; Ethambutol | 1974 |